At the effective time of the Scheme, Robert A. Michael, Scott Reents, Ryan Quigley, Andres Rodrigo and Basil Blakeney became directors of Allergan plc and each of Brenton L. Saunders, Christopher W. Bodine, Nesli Basgoz, Christopher J. Coughlin, Adriane M. Brown, Joseph H. Boccuzi, Carol Anthony (John) Davidson, Thomas C. Freyman, Michael E. Greenberg, Robert J. Hugin and Peter J. McDonnell tendered their respective resignations as directors from the board of directors of Allergan and from all committees of the board of directors of Allergan on which such directors served, effective as of the effective time of the Scheme.